A detailed history of Sather Financial Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Sather Financial Group Inc holds 2,027 shares of ABT stock, worth $230,794. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,027
Previous 2,087 2.87%
Holding current value
$230,794
Previous $237,000 11.39%
% of portfolio
0.02%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$100.73 - $112.44 $6,043 - $6,746
-60 Reduced 2.87%
2,027 $210,000
Q3 2022

Oct 21, 2022

SELL
$96.76 - $112.03 $62,894 - $72,819
-650 Reduced 23.75%
2,087 $202,000
Q1 2022

Apr 29, 2022

BUY
$114.02 - $139.04 $312,072 - $380,552
2,737 New
2,737 $324,000
Q3 2018

Nov 07, 2018

SELL
$60.81 - $73.36 $369,907 - $446,248
-6,083 Closed
0 $0
Q2 2018

Aug 03, 2018

BUY
$57.57 - $63.54 $4,778 - $5,273
83 Added 1.38%
6,083 $371,000
Q2 2017

Aug 15, 2017

BUY
N/A
6,000
6,000 $292,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sather Financial Group Inc Portfolio

Follow Sather Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sather Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sather Financial Group Inc with notifications on news.